MetaADEDB 2.0 @ LMMD
Tegafur
(WFWLQNSHRPWKFK-UHFFFAOYSA-N)
Structure
SMILES
O=c1[nH]c(=O)n(cc1F)C1CCCO1
Type(s)
Approved; Investigational
ATC code(s)
L01BC03; L01BC53
Molecular Formula:
C8H9FN2O3
Molecular Weight:
200.167
Log P:
-0.0153
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
64.09
CAS Number(s):
17902-23-7; 37076-68-9; 79107-97-4; 82294-77-7
Synonym(s)
1.
Tegafur
2.
1-(2-Tetrahydrofuryl)-5-fluorouracil
3.
1-(Tetrahydro-2-furanyl)-5-fluorouracil
4.
5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione
5.
FT-207
6.
FT207
7.
Florafur
8.
Fluorofur
9.
Ftorafur
10.
Futraful
11.
N1-(2'-Tetrahydrofuryl)-5-fluorouracil
12.
Sunfural S
13.
Uftoral
14.
Utefos
15.
FT 207
External Link(s)
MeSHD005641
PubChem Compound5386
ChEBI32188
CHEMBLCHEMBL20883
DrugBankDB09256
DrugCentral4398
IUPHAR/BPS Guide to PHARMACOLOGY10513
KEGGcpd:C12673
dr:D01244
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1LeukoencephalopathyFAERS: 1OFFSIDES
US FAERS
2Toxicity to various agentsFAERS: 1US FAERS
3Acute myocardial infarctionOFFSIDES
4Adams-Stokes SyndromeOFFSIDES
5Adverse eventOFFSIDES
6Altered state of consciousnessOFFSIDES
7AmphetaminesOFFSIDES
8Anemia, Macrocytic2117887CTD
9Angina Pectoris, Variant3150118CTD
10AnorexiaOFFSIDES
11Antithrombin III increasedOFFSIDES
12ApathyOFFSIDES
13Arterial thrombosisOFFSIDES
14AscitesOFFSIDES
15Atrial tachycardiaOFFSIDES
16Biliary sepsisOFFSIDES
17BlepharoptosisOFFSIDES
18BlepharospasmOFFSIDES
19Blood albumin decreasedOFFSIDES
20Blood creatinine increasedOFFSIDES
21Blood fibrinogen increasedOFFSIDES
22Blood pH decreasedOFFSIDES
23Blood sodium increasedOFFSIDES
24Blood sodiumOFFSIDES
25Blood urea increasedOFFSIDES
26Cancer PainOFFSIDES
27Catheter site painOFFSIDES
28Cerebellar AtaxiaOFFSIDES
29Colonic Diseases15006714CTD
30CyanosisOFFSIDES
31DehydrationOFFSIDES
32DermatomyositisOFFSIDES
33DiarrheaOFFSIDES
34Disseminated Intravascular Coagulation1729088CTD
35Diverticular perforationOFFSIDES
36Duodenal ulcer perforationOFFSIDES
37DysuriaOFFSIDES
38Electrocardiogram repolarisation abnormalityOFFSIDES
39EnterocolitisOFFSIDES
40Eosinophilic myocarditisOFFSIDES
41Febrile NeutropeniaOFFSIDES
42Fever1268838CTD
43Gastrointestinal Diseases1268838CTD
44Gastrointestinal Neoplasms1268838CTD
45Gastrointestinal cancer metastaticOFFSIDES
46Gastrointestinal perforationOFFSIDES
47Hyperesthesia15206584CTD
48IncontinenceOFFSIDES
49Kidney Diseases6412636CTD
50Kidney FailureOFFSIDES
51Leukopenia neonatalOFFSIDES
52Lung Neoplasms1268838
1729088
CTD
53Malignant neoplasm progressionOFFSIDES
54Maximal Voluntary VentilationOFFSIDES
55MyelitisOFFSIDES
56Neoplasm Metastasis12720104CTD
57Neoplasms338900CTD
58Neutrophil count decreasedOFFSIDES
59Oculogyric crisisOFFSIDES
60Pancreatic carcinoma recurrentOFFSIDES
61ParaplegiaOFFSIDES
62Peripheral embolismOFFSIDES
63PeritonitisOFFSIDES
64Phlebitis1268838CTD
65PneumopericardiumOFFSIDES
66Prothrombin time ratio increasedOFFSIDES
67RhabdomyolysisOFFSIDES
68Seizures15206584CTD
69Skin ErosionOFFSIDES
70Skin necrosisOFFSIDES
71Stomach Neoplasms2117887
6412636
18537153
CTD
72SubileusOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.